I think EVO had insider buying recently** I should probably double check that.... This next company interests me--- Blue Water initiated with a Buy at H.C. Wainwright 06:13 BWV H.C. Wainwright analyst Vernon Bernardino initiated coverage of Blue Water Vaccines with a Buy rating and $7 price target. The company's "versatile" vaccine programs show promise to overcome current vaccine challenges, Bernardino tells investors in a research note. He is bullish on BWV-201's ability to prevent non-invasive S. pneumoniae infections in a serotype independent manner.
I'm going to teach you all today how to treat aloss. We dumped MRTX after the horrid news it was around $76. We lost $10 on the trade. We think the name dead money now except for a buyout that is in the works perhaps -- We wait for the downgrades which came yesterday. and we can now re buy the name at a lower price with less risk baked into the name.
MRTX re entry @ $44 Stifel cuts Mirati price target to $73, says move lower 'overdone' 07:20 MRTX Stifel analyst Benjamin Burnett lowered the firm's price target on Mirati Therapeutics to $73 from $106 and keeps a Buy rating on the shares, arguing that the stock's move lower has been "overdone" even though he says the KRYSTAL-7 data "represent a significant setback relative to our expectations." However, the regimen "looks about as active as pembro+chemo" and management outlined a strategy to test adagrasib+pembro against pembro monotherapy in PD-L1 high patients, which he thinks could succeed. Assuming adagrasib+pembro has a 65% probability-of-success in only the PD-L1 high first-line NSCLC population, he estimates the potential for $503M risk-adjusted revenue at peak, Burnett tells investors.
Part of our generators for Ukraine Portfolio. TT, CARR & Caterpillar price target raised to $264 from $240 at Cowen
If you are watching the news this RSV is sweeping the nation and making kids sick. The shelves are running out of cold meds... Enanta initiated with a Buy at H.C. Wainwright H.C. Wainwright analyst Ed Arce initiated coverage of Enanta Pharmaceuticals with a Buy rating and $56 price target. The analyst says that while the company's COVID program draws interest, his positive thesis relies on its RSV program. RSV is a large, untapped opportunity that affects vulnerable patients, Arce tells investors in a research note.<--------!
The children Stoney! How many times have I told you, no one cares how many shares you bought. They need guidance. You abandoned them. The last thing we heard was to buy, the stock starts falling and you disappear. You (conveniently) closed this dog at $74, but you left the readers high and dry. Unfortunately VZ doesn't check on all your stocks daily or I would have seen this disaster coming. Re The Lizard King... give up. 0-6
3961 Lizard King went long S&P contracts yesterday afternoon right around 3961. Fingers crossed for today and next Friday. I think we had a few days of tax loss selling. I should of been more aware of that since I am the guy that created the indicator! lol. I take my cues from the 15th of the quarterlies 4 times a year you pay on the 15th. However end of year is tax selling as well.. losses. Due to the ups and downs of the market I assumed everyone had already rotated out of bad tech. I certainly had. Apparently I was wrong!
I could use some advice here from the children. The reason i needed to cool off for a day or two is not Mirati! Like I said I am a seasoned Bio investor you get your hits and misses in that space but rather an incredible bad move on SIG. Signant jewelry I had in all accounts and then for reasons I cannot remember (Earnings) I chickened out and flipped into Sketchers. The stock went crazy. The anger that wells up in me when I do that... it's not a pretty scene. I've been known to go buy crazy and buy my way out of trouble with a series of stock purchases after missing a big run... I was afraid that was the direction I was going... Now what? Any meat left on the bone at SIG? How much of a loser will I look like if I flip again. (this is done through HF)
The Lizard King abandoned the children and has been completely wrong as the S&P remains range-bound. VZ making $'s for the readers. 3 HUGE winners yesterday alone. 750 page-views in 24 hours while you orphaned the readers.